Clarifying IVIG Dosing Regimen Recommendations in the 2025 ASRI Guidelines for Recurrent Pregnancy Loss.

Saved in:
Bibliographic Details
Title: Clarifying IVIG Dosing Regimen Recommendations in the 2025 ASRI Guidelines for Recurrent Pregnancy Loss.
Authors: Lin LT; Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan (ROC)., Lu CC; Division of Rheumatology, Immunology, and Allergy, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan (ROC)., Tsui KH; Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan (ROC).
Source: American journal of reproductive immunology (New York, N.Y. : 1989) [Am J Reprod Immunol] 2026 May; Vol. 95 (5), pp. e70245.
Publication Type: Letter
Journal Info: Publisher: Wiley-Blackwell Country of Publication: Denmark NLM ID: 8912860 Publication Model: Print Cited Medium: Internet ISSN: 1600-0897 (Electronic) Linking ISSN: 10467408 NLM ISO Abbreviation: Am J Reprod Immunol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1600-0897
DOI:10.1111/aji.70245